<p>Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous and meaningful improvements in bone minera
<p> <br /> </p> <div> <article> <p>UK and Euro Area PMI cast a shadow as recession talk returns. Todays data also adds an interesting dynamic to the ECB policy movi
Leave a Comment